Nabriva Therapeutics plc (NBRVF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 1, 2025, 4:00 PM EST

Nabriva Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2013 - 2017
Period Ending
Apr '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2013 - 2017
Market Capitalization
06345112598
Upgrade
Market Cap Growth
-57.98%-82.95%-33.41%-59.13%27.62%-55.43%
Upgrade
Enterprise Value
-2-3-101983-2
Upgrade
Last Close Price
0.001.8914.9760.50330.00365.00
Upgrade
PS Ratio
0.000.161.1810.1513.1610.13
Upgrade
PB Ratio
-0.301.760.641.543.021.43
Upgrade
P/TBV Ratio
-1.760.641.543.031.43
Upgrade
EV/Sales Ratio
0.12--3.778.71-
Upgrade
Debt / Equity Ratio
-0.031.590.150.230.840.35
Upgrade
Asset Turnover
0.900.660.420.070.090.09
Upgrade
Inventory Turnover
-3.902.544.88--
Upgrade
Quick Ratio
0.250.692.712.445.356.04
Upgrade
Current Ratio
0.381.133.593.095.486.11
Upgrade
Return on Equity (ROE)
-602.21%-201.91%-114.36%-186.76%-150.61%-152.33%
Upgrade
Return on Assets (ROA)
-92.85%-61.56%-43.53%-54.18%-48.58%-49.91%
Upgrade
Return on Capital (ROIC)
-234.16%-99.24%-59.33%-70.87%-59.10%-58.92%
Upgrade
Earnings Yield
-17044582.04%-987.50%-145.57%-136.22%-66.32%-117.37%
Upgrade
FCF Yield
-4032198.14%-637.59%-175.40%-140.06%-57.66%-74.60%
Upgrade
Buyback Yield / Dilution
-34.65%-54.67%-237.48%-73.12%-46.07%-70.28%
Upgrade
Updated Oct 19, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.